Clinicopathological features of non-conventional renal cell carcinoma histological subtypes: Learning points from a large contemporary series spanning over three decades-Reference-Cited by-同舟云学术

Clinicopathological features of non-conventional renal cell carcinoma histological subtypes: Learning points from a large contemporary series spanning over three decades

Published:2022 Issue:2 Volume:63 Page:151
ISSN:2466-0493
Container-title:Investigative and Clinical Urology
language:en
Short-container-title:Investig Clin Urol

Author:

Lim Ee Jean¹^ORCID,Fong Khi Yung²^ORCID,Li Jingqiu¹^ORCID,Huang Hong Hong¹,Chen Kenneth¹^ORCID,Tay Kae Jack¹^ORCID,Cheng Christopher Wai Sam¹,Ho Henry Sun Sien¹,Ngo Nye Thane³^ORCID,Yuen John Shyi Peng¹^ORCID

Affiliation:

1. Department of Urology, Singapore General Hospital, Singapore.

2. Yong Loo Lin School of Medicine, National University of Singapore, Singapore.

3. Department of Pathology, Singapore General Hospital, Singapore.

Publisher

The Korean Urological Association

Subject

Urology

Link

https://icurology.org/pdf/10.4111/icu.20210373

Reference18 articles.

1. Rising Incidence of Renal Cell Cancer in the United States

2. The International Society of Urological Pathology (ISUP) Vancouver Classification of Renal Neoplasia

3. The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs—Part A: Renal, Penile, and Testicular Tumours

4. AJCC cancer staging manual [Internet]. New York. Springer International Publishing. 2017. cited 2021 May 12. Available from: https://www.springer.com/gp/book/9783319406176

5. Global analysis of metastasis-associated gene expression in primary cultures from clinical specimens of clear-cell renal-cell carcinoma

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Outcomes of Localized Renal Cell Carcinoma Across Different Races;Clinical Medicine & Research;2023-09

2. Contrast‐enhanced ultrasound ( CEUS ) of benign and malignant renal tumors: Distinguishing CEUS features differ with tumor size;Cancer Medicine;2022-09-04